Avandia may come with stronger warnings, sources say

10/24/2007 | Wall Street Journal (free content), The

The FDA is pushing for a "black box" warning on labels of GlaxoSmithKline's diabetes drug Avandia to include information about the treatment's heart attack risk, officials familiar with the issue say. A GSK spokeswoman said the drug giant is "working diligently with the FDA to finalize the label" on Avandia, which already carries a "black box" warning about heart failure.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA